20-RHCO-P-603_ JA signed_.pdf

Control No. 20-RHC0-P-603

Version – March 2017 FOR OFFICIAL USE ONLY

JUSTIFICATION REVIEW DOCUMENT

FAR SUBPART 13.5 SIMPLIFIED PROCEDURES

COMMERCIAL ITEMS – UNDER THE SIMPLIFIED ACQUISITION THRESHOLD

(Simplified Acquisition Threshold < $250K)

JUSTIFICATION AND APPROVAL

1. Contracting Activity: Regional Health Contracting Office-Pacific, Health Contracting Cell, Joint Base Lewis-McChord (JBLM), 673 Woodland Square Loop SE, Lacey WA 98503.

2. Description of Action: Madigan Army Medical Center (MAMC), Dept. of Pathology Services, JBLM, Tacoma, WA is requesting a follow-on Base + 1yr Option for a no cost trade-in Government-Owned Sebia Capillary Electrophoresis Analyzer to include;

reagents, supplies, training and service.

An acquisition plan is not required because this procurement does not meet the threshold at Defense Federal Acquisition Regulation Supplement 207.103(d)(i)(B).

(Insert approval authority title) approved an acquisition plan in accordance with DFARS 207.103(d)(i)(B) on (insert date).

The required acquisition plan in accordance with DFARS 207.103(d)(i)(B) is currently awaiting (insert approval authority title) approval.

Name of Intended Contractor: Sebia, Inc.

Street Address: 1705 Corporate Drive STE 400 City, State, Zip: Norcross, GA 30093-2991

3. Description of Supplies/Services: MAMC, Department Pathology Services, Tacoma WA is requesting a follow-on Base Year, with (1) Option year award for a Sebia Capillary 3 Octa Electrophoresis Analyzer and reagents, supplies, and training.

This contract action will include a trade-in of the current analyzer at MAMC. At the end of the contract period, MAMC will own the analyzer.

Period of Performance, or Date of Delivery: 01 October 2020 through 30 September

Total Value: $ 190,000.00

For Actions with One Option.

Base Period: 01 October 2020 to 30 September 2021 Option Period 1: 01 October 2021 to 30 September 2022

Value: $95,000.00 Value: $95,000.00

FAR Clause 52.217-8 Option to Extend the Terms of the Contract, will be included in the contract.

4. Authority Cited: Simplified Procedures for Certain Commercial Items, 41 U.S.C. 1901 (or 41 U.S.C. 1903 for Special Emergency Procurement) as implemented by FAR Subpart 13.5:

Unusual and compelling urgency Exclusive licensing & proprietary agreements Industrial mobilization Other: Only one source reasonably available;

5. Reason for Authority Cited: Only one (1) manufacturer provides FDA-approved, fully automated Capillary Electrophoresis reagents, supplies, and consumables for a government owned hemoglobin electrophoresis analyzer based on the search function of GSA, GSS, Cardinal Health Market as well as Google, discussions with various vendors, and review of CAP proficiency testing results: Sebia Inc. Sebia is the only vendor that meets 100% of the required government owned Hemoglobin Electrophoresis Analyzer requirements.

Automation provides the greatest leap forward for providing the highest quality patient test results in the shortest time period. Automation helps to reduce the need for physicians to have to order STAT tests because all tests are handled and results are reported in the shortest time period possible. With automation, long term staffing requirements are reduced thereby saving in civilian personnel costs. Other vendors do not have fully automated analyzers.

6. Efforts to Obtain Competition: In accordance with FAR 5.201 this action with the J & A will be posted as a Special Notice of Intent to FBO.

7. Actions to Increase Competition: No action on the part of this office will decrease any barrier to competition available. JBLM-HCB, as well as the Department of Pathology, will continuously monitor any changes in this requirement. As Technology becomes available, research will be performed to consider other possible sources that may meet or exceed this current requirement.

8. Market Research: This requirement is for Invitro Reagents / Trade-In Analyzer, FSC 6550 (Class VIII). Details, including key work searches described in the Market Research report which supports this J & A can be found in the PCF File under Market Research. Market Research has been conducted by searching the Dynamic Small Business search using NAICS Code: 325413. Results from the research did not locate any small businesses that could provide the above products meeting the salient characteristics as determined.

9. Interested Sources: To date, other than Sebia, Inc. no other sources have written to express interest in the acquisition.

10. Other Facts:

a. Procurement History

Previous Contract or Purchase Order Number: W81K0216F0049 or N/A

Previously competed? N/A No X Yes Previous authority for less than Full & Open Competition: FAR 13.106-1(b)(1)(i)

11. Technical / Requirements Certification: I certify that the supporting data under my cognizance which are included in the justification are accurate and complete to the best of my knowledge and belief.

GIEDD.JAMES.L

Digitally signed by

GIEDD.JAMES.LYLE.1044490567

Signature: YLE.1044490567 Date: 2020.09.24 11:02:24 -07'00'

Submitted By: James Giedd Position Title: MAMC, Core Laboratory Supervisor Email Address: James.l.Giedd.civ@mail.mil Date: 24 September 2020

12. Fair and Reasonable Cost Determination: I hereby determine that the anticipated cost or price to the Government for this contract action will be fair and reasonable.

This determination will be made using the following: price analysis cost analysis IGCE audit: other: Prior award action representing similar or exact requirements for these products under award W81K0216F0049.

As a part of this basis, certified cost or pricing data is not required because the item and/or services being acquired are considered commercial.

13. Contracting Officer Certification: I certify that this justification is accurate and complete to the best of my knowledge and belief.

Signature:

BARR.SCOTT.A.107

8903208

Digitally signed by

BARR.SCOTT.A.1078903208

Date: 2020.09.24 14:48:32 -07'00'

Typed Name: Scott A. Barr Position Title: Contracting Officer Email Address: Scott.a.Barr.civ@mail.mil Date: 24 September 2020 mailto:James.l.Giedd.civ@mail.mil mailto:Scott.a.Barr.civ@mail.mil